AzTrials
AzTrials

Primary Percutaneous Coronary InterventionNCT06825780

Short Term Outcomes of Primary Percutaneous Coronary Intervention (PCI) Patients Presented With Acute Heart Failure in Assuit University Heart Hospital

An observational study of Primary Percutaneous Coronary Intervention, run by Assiut University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Observational study outcome of PCI in patients presented with acute heart failure Read more about this study

Who is it for?
Ages 18 years and older
How many people
200 participants
Where
1 siteEgypt
Study dates
3 Mar 2025to 1 Jan 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: assiut university heart hospital

Who may be able to join

  • age more than 18 years
  • acute heart failure
  • PCI

Who cannot join

  • NSTEMI
  • end stage renal disease

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

sanaa abdelnasser, master contact

01095165354

sanaagamal143@gmail.com

mahmoud abdelsabour, staff contact

01001202779

m_abd_elsabour@yahoo.com

Egypt1 site
  • Heart Hospital

    Asyut, Heart Hospital

Other trials in Egypt

About this study

Observational study outcome of PCI in patients presented with acute heart failure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hospital mortality and complication post PCI

    number of mortality cases

    Measured: within 3 month

Secondary outcomes (1)
  1. major adverse cardiac events

    myocardial infarction heart failure

    Measured: within 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study start3 Mar 2025 (estimated)
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion1 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06825780
Sponsor's protocol ID
PCI.HF
Status last verified
Feb 2025
First submitted
8 Feb 2025
Last updated
13 Feb 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lembo NJ, Karmpaliotis D, Kandzari DE. CTO PCI Procedural Planning. Interv Cardiol Clin. 2012 Jul;1(3):299-308. doi: 10.1016/j.iccl.2012.04.002. Epub 2012 Jun 5.

    PubMed 28582014

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Percutaneous Coronary Intervention, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact sanaa abdelnasser, master (01095165354, sanaagamal143@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hospital mortality and complication post PCI (time frame: within 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06825780, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in